Literature DB >> 19168133

Mendelian forms of Parkinson's disease.

Thomas Gasser1.   

Abstract

Over the last few years, genetic findings have changed our views on Parkinson's disease (PD), as mutations in a growing number of genes are found to cause monogenic forms of the disorder. Point mutations in the gene for alpha-synuclein, as well as duplications and triplications of the wild-type gene cause a dominant form of PD in rare families, pointing towards mishandling of this protein as a crucial step in the molecular pathogenesis of the disorder. Mutations in the gene for leucine-rich repeat kinase 2 (LRRK2) have recently been identified as a much more common cause for dominant PD, while mutations in the parkin gene, in DJ-1, PINK1 and ATP13A2 all cause autosomal-recessive parkinsonism of early onset. Mutations in recessive genes probably are pathogenic through loss-of-function mechanisms, suggesting that their wild-type products protect dopaminergic cells against a variety of insults. Evidence is emerging that at least some of these genes may play a direct role in the etiology of the common sporadic form of PD. Further, it is likely that the cellular pathways identified in rare monogenic variants of the disease also shed light on the molecular pathogenesis in typical sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168133     DOI: 10.1016/j.bbadis.2008.12.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  60 in total

Review 1.  Neuroproteomics approaches to decipher neuronal regeneration and degeneration.

Authors:  Faneng Sun; Valeria Cavalli
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

Review 2.  Mechanisms of LRRK2-mediated neurodegeneration.

Authors:  Elpida Tsika; Darren J Moore
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

Review 3.  The role of autophagy in Parkinson's disease.

Authors:  Melinda A Lynch-Day; Kai Mao; Ke Wang; Mantong Zhao; Daniel J Klionsky
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

4.  A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity.

Authors:  Julien Dusonchet; Hu Li; Maria Guillily; Min Liu; Klodjan Stafa; Claudio Derada Troletti; Joon Y Boon; Shamol Saha; Liliane Glauser; Adamantios Mamais; Allison Citro; Katherine L Youmans; LiQun Liu; Bernard L Schneider; Patrick Aebischer; Zhenyu Yue; Rina Bandopadhyay; Marcie A Glicksman; Darren J Moore; James J Collins; Benjamin Wolozin
Journal:  Hum Mol Genet       Date:  2014-05-02       Impact factor: 6.150

5.  Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Kevin C Ess; Keith M Erikson; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2012-10-22       Impact factor: 4.294

6.  DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.

Authors:  Chenere P Ramsey; Elpida Tsika; Harry Ischiropoulos; Benoit I Giasson
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

7.  The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.

Authors:  Teresa G Hastings
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

8.  Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons.

Authors:  João Paulo L Daher; Mingyao Ying; Rebecca Banerjee; Rebecca S McDonald; Myriam Dumas Hahn; Lichuan Yang; M Flint Beal; Bobby Thomas; Valina L Dawson; Ted M Dawson; Darren J Moore
Journal:  Mol Neurodegener       Date:  2009-07-24       Impact factor: 14.195

9.  Spatial distribution of Parkinson's disease mortality in Spain, 1989-1998, as a guide for focused aetiological research or health-care intervention.

Authors:  Jesús de Pedro-Cuesta; Eduard Rodríguez-Farré; Gonzalo Lopez-Abente
Journal:  BMC Public Health       Date:  2009-12-02       Impact factor: 3.295

10.  Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle.

Authors:  Kristen A Malkus; Elpida Tsika; Harry Ischiropoulos
Journal:  Mol Neurodegener       Date:  2009-06-05       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.